All In MedTech

FDA Clearance Tracker · P150038-S008

ExAblate (Model 4000) System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 24, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 24, 2018

Approved

Time to decision

93 days

Received Jul 23, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150038-S008
Device name
ExAblate (Model 4000) System
Applicant
Insightec
Applicant location
Tirat Carmel
Received
Jul 23, 2018
Decided
Oct 24, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P150038

Device type

Device class
Class III

Every decision under product code POH

FDA's approval statement

As written in FDA's record.

Approval to include the 2-year and 3-year post-market study outcomes in the device labeling.

Source documents

Other decisions for Insightec

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.